Determination of thyroid hormones in pharmaceutical preparations, after derivatization with 9-anthroylnitrile, by high-performance liquid chromatography with fluorescence detection

Development of a selective fluorescence derivatization strategy for thyroid hormones based on the Sonogashira coupling reaction

A new fluorescence derivatization technique for the determination of the thyroid hormones, 3,3',5-triiodo-L-thyronine (T₃, triiodothyronine) and 3,3',5,5'-tetraiodo-L-thyronine (T₄, L-thyroxine), in human serum was developed based on the Sonogashira coupling reaction. This derivatization reaction was recently utilized by our research group as a promising solution for the derivatization of ortho-substituted aryl halides that suffer from steric hindrance. T₃ and T₄ possess amino groups that could be derivatized by many reagents; however, these reagents are not useful in the case of biological analysis as they could non-selectively react with many biogenic amines and amino acids. Thus, herein we aimed at labeling the iodo-phenyl group of T₃ and T₄ as a selective fluorescence labeling approach suitable for biological analysis. The fluorescent alkyne, 2-(4-ethynylphenyl)-4,5-diphenyl-1H-imidazole (DIB-ET), can label the ortho-substituted aryl halides T₃ and T₄ in the presence of palladium and copper as catalysts, overcoming the steric hindrance of ortho-substitution. Furthermore, the application of the proposed method for the selective analysis of T₃ and T₄ in biological samples was successfully performed even in the presence of numerous biological components. The formed fluorescent derivatives produced from the reaction of DIB-ET and T₃ and T₄ could be determined by an HPLC system with fluorescence detection. The proposed method was successfully applied for the selective and sensitive determination of T₃ and T₄ in human serum with detection limits (S/N = 3) of 4.0 and 6.1 ng/mL and the recovery rate in the ranges of 84.3-92.1% and 81.3-84.9%, respectively. Therefore, the proposed method could be used as a new simple tool for the simultaneous determination of T₃ and T₄ in biological samples.

A feasible method for indirect quantification of L-T4 in drugs by iodine determination

In this work, a method combining microwave-induced combustion (MIC) for sample preparation of commercial levothyroxine sodium (L-T₄) drugs (L-T₄: 25-200µg/tablet), and potentiometry with ion selective electrode (ISE) for iodine determination and subsequent indirect quantification of L-T₄ was proposed. The type and concentration of the absorbing solution were evaluated to select the most suitable conditions for this study. Using the MIC method, it was possible to use solutions as diluted as 150mmolL^-1 (NH₄)₂CO₃ (for samples containing 25-200µg of L-T₄/tablet) for I absorption. In these conditions, recoveries for L-T₄ were between 99% and 101%, and relative standard deviations were lower than 10%. The limit of detection for L-T₄ was 11.2µg/tablet, which is almost two times lower than the minimum concentration of L-T₄ in commercially available drugs. Thus, the MIC was suitable for the digestion of several L-T₄ drugs for subsequent I determination by ISE and indirect quantification of L-T₄. Furthermore, the proposed method presents high throughput with low reagent consumption and consequently lower waste generation, making it suitable for routine determination of L-T₄ in drugs. From the obtained results, it was possible to observe that one of the analyzed samples is not in agreement with the limits established by the United States Pharmacopeia, indicating the importance of the drug quality control. The United States Pharmacopeia establishes that each tablet must contain between 90% and 110% of the amount of active substance declared by the manufacturer.

Enantioselective resolution of thyroxine hormone by high-performance liquid chromatography utilizing a highly fluorescent chiral tagging reagent

A highly fluorescent chiral tagging reagent, 4-(3-isothiocyanatopyrrolidin-1-yl)-7-(N,N-dimethylaminosulfonyl-2,1,3-benzoxadiazole, [R(-)-DBD-PyNCS], was employed to develop an indirect resolution method for efficient separation of thyroxine enantiomers,D-T(4) and L-T(4). The reaction of R(-)-DBD-PyNCS with the thyroxine enantiomers proceeds effectively at 40 degrees C for 20 min in the presence of basic medium to produce the corresponding pair of diastereomers. No racemization occurs during the tagging reaction under the optimized conditions. Various experimental parameters for derivatization reaction including the species of catalyst, the concentration of tagging reagent and reaction temperatures, have been examined to get a highest yield for T(4) derivatives. The structure of T(4) derivatives was identified based on ESI-MS/MS measurements in negative mode. The efficient separation of D-, L-T(4) derivatives was achieved by isocratic elution with water-acetonitrile mobile phase containing 1% AcOH on a reversed phase column utilizing a conventional fluorescence detector. The resolution (Rs) value of the diastereomers derived from thyroxine was 5.1. The calibration curves of both the D-T(4) and L-T(4) were linear over the concentration range of 0.1-20 microg/ml. The limits of detection (S/N = 3) for both D-T(4) and L-T(4) were 0.2 ng per injection. The proposed method was applied to the determination of D-T(4) and L-T(4) in pharmaceutical formulations and human serum samples.

Development of a validated HPLC method for the determination of iodotyrosines and iodothyronines in pharmaceuticals and biological samples using solid phase extraction

Identification, separation and quantitation of iodoaminoacids, is essential for the biological research and the clinical diagnosis of thyroid gland disease. Under this aspect a reversed-phase high-performance liquid chromatographic method was developed for the determination of thyroid gland hormones and some of their primary metabolites, 3,3',5,5'-tetra-iodo-L-thyronine (L-thyroxine), 3,3',5-tri-iodo-L-thyronine, 3,5-di-iodo-L-thyronine, L-thyronine, 3,5-di-iodo-L-tyrosine, 3-iodo-L-tyrosine and l-tyrosine. Analysis was performed on an Inertsil C(18) column with photodiode-array detection, using a 25 min gradient scale program of a binary mobile phase consisted of 0.1% aqueous solution of trifluoroacetic acid at pH 3 as solvent A and acetonitrile as solvent B, at a flow rate of 1 mL/min. Quantitation was performed using were obtained using theophylline as internal standard. The method was applied to commercial pharmaceuticals and biological samples (serum, urine and tissue). Drug-free urine and serum samples were spiked with known concentrations of the analytes standards and pretreated by solid phase extraction to remove matrix interferences. C(18) cartridges were used, yielding recoveries ranging from 87.1% to 107.6% for serum samples and from 92.1% to 98.7% for urine samples. With regard to total-T(4) concentrations in serum samples, results are cross-validated with RIA and found to agree well.